
Can Biotech Transform Your Portfolio?
WT
AB
Will Tamplin, senior analyst at Fairlead Strategies, joins Ash Bennington to discuss his strategy for leveraging opportunities in the biotech sector amid market volatility — and how $XBI can have an outsized impact on your portfolio.
